|
 |
IfosfamideThis page contains recent news articles, when available, and an overview of Ifosfamide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ifosfamide (when available) Ifosfamide selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of Ifosfamide-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed. For third line chemotherapy of germ cell testicular cancer. It should ordinarily be used in combination with a prophylactic agent for hemorrhagic cystitis, such as mesna Mechanism Of Action: After metabolic activation, active metabolites of ifosfamide alkylate or bind with many intracellular molecular structures, including nucleic acids. The cytotoxic action is primarily due to cross-linking of strands of DNA and RNA, as well as inhibition of protein synthesis. News Articles on Ifosfamide Zeltia's Yondelis Wins NICE Backing as Panel Reverses Decision - Dec 20, 2009 NICE has recommended the use of Yondelis as a treatment when other medicines -- anthracyclines and ifosfamide -- have failed or if patients are intolerant ... Bloomberg Atypical presentation of angiosarcoma of the scalp in the setting of Human ... - Dec 19, 2009 The patient was treated with a course of ifosfamide and anthracyline based chemotherapy. Disease progression was noted on chemotherapy and she was ... 7thSpace Interactive (press release) Conflictul alimente – medicamente - Jan 4, 2010 Vinblastine, ifosfamide), răceala (Dextromethorphan), disfuncÅ£iile erectile (Viagra) sau anticoncepÅ£ionalele. CaÅŸcavalul, telemeaua, brânza de burduf, ... Jurnalul Naţional ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress - Nov 11, 2009 Palifosfamide (Zymafos TM or ZIO-201) references a novel composition (tris formulation) that is the functional active metabolite of ifosfamide, ... Business Wire (press release) 'Doxo' Going to Like This One: Ziopharm's Phase II Wins Big - Nov 6, 2009 Once we're through partnering, we'll pull the trigger on Phase I." Since palifosfamide is the functional active metabolite of ifosfamide - a standard of ... BioWorld Online Ziopharm Shows Positive Results (NASDAQ:ZIOP) - Nov 9, 2009 Palifosfamide (Zymafos or ZIO-201) is a novel composition (tris formulation) that is the functional active metabolite of ifosfamide, a standard of care for ... FavStocks (blog) 난소암 ì¹˜ë£Œì œ '욘ë?¸ë¦¬ìŠ¤' EUì„œ 발매 - Nov 2, 2009 ...욘ë?¸ë¦¬ìŠ¤'ë?¼ë©´ 지난 1988ë…„ ì?´í?¬ìŠ¤íŒŒë§ˆì?´ë“œ(ifosfamide)ê°€ FDAì?˜ 승ì?¸ì?„ ë°›ì?€ ì?´í›„ 20년만ì—? 등장한 ì—°ì¡°ì§? 육종 ì¹˜ë£Œì œë¡œ ì‹œì„ ì?´ ì? 리게 í–ˆë?˜ í•ì•”ì œ. ... 약업신문 Ifosfamide (Systemic). - Jul 28, 2005 Ifosfamide ( eye-FOS-fa-mide) belongs to the group of medicines called alkylating agents. It is used to treat cancer of the testicles as well as some other ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Ifosfamide (Systemic).(Drug overview) - May 1, 2006 Ifosfamide ( eye-FOS-fa-mide) belongs to the group of medicines called alkylating agents. It is used to treat cancer of the testicles as well as some other ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Ifosfamide neurotoxicity and potential treatment with methylene blue - Apr 25, 2008 ...by Lisa Lohr, PharmD. Ifosfamide is an antineoplastic agent useful in the treatment of a wide range of cancers including sarcomas, gynecologic cancers, ... HemOncToday IFOSFAMIDE (Intravenous route) - eye-FOS-fa-mide.(Drug overview) - May 1, 2007 Ifosfamide should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com ZIOPHARM Presents Preliminary ZIO-201 Clinical Results at ASCO - Jun 5, 2006 These data support the Company's premise that certain adverse events associated with ifosfamide, an approved cancer drug extensively used in the United ... Genetic Engineering News - Genetic Engineering News (press release) Holoxan - Ifosfamide - Medical Drug - Jan 6, 2006 Ifosfamide is an alkylating agent. This is a type of antineoplastic agent that works by interfering with DNA in a number of ways. ... Virtual Medical Centre - The Virtual Medical Centre Combined heart and lung transplantation for unresectable primary … - Aug 1, 2007 He received 2 cycles of chemotherapy with mesna, doxorubicin, ifosfamide, ... The patient was treated with ifosfamide chemotherapy and sequentially with two ... The Journal of Thoracic and Cardiovascul... Combination Chemotherapy of Ifosfamide, 5-Fluorouracil, Etoposide and... - Sep 16, 2008 To evaluate the efficacy and toxicity of perioperative combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP) in bladder ... UroToday International Journal ZIOPHARM Oncology Announces ZIO-201 ASH Abstract Publication - Nov 21, 2005 Mesna(R), which is used as an "uroprotective" agent with ifosfamide, does not need to be given with ZIO-101. A Phase I/II study with ZIO-201 in people with ... RedOrbit ZIOPHARM Presents ZIO-201 Preclinical Kidney Toxicity Data at Bone … - Feb 21, 2006 Cyclophosphamide and ifosfamide are widely used anti-cancer pro-drugs that have to be metabolized to be ... ZIO-201 is the active metabolite of ifosfamide. ... RedOrbit ZIOPHARM Presents Positive Darinaparsin Phase II Data at ASH Meeting - Dec 8, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It is expected to overcome the resistance of ifosfamide and cyclophosphamide in ... Genetic Engineering News - Genetic Engineering News (press release) Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European ... - Jul 9, 2007 Of these 5 patients, 2 had progressed through prior ifosfamide (IFOS) ... "Ifosfamide is one of the few effective standard therapies available for most ... Free with registration - Business Wire - AccessMyLibrary.com … Cancer; Concurrent radiation and combined bleomycin, ifosfamide, … - Feb 14, 2005 The information in this article comes under the subject areas of Cervical Cancer, Oncology, Radiation Therapy, Bleomycin, Ifosfamide, Cisplatin, ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Threshold Pharmaceuticals, Inc. at NewsMakers in the Biotech Industry... - Sep 7, 2006 And in fact Glufosfamide, which is a simple conjugate of glucose with an approved alkylating drug Ifosfamide, takes advantage of these up regulated glucose ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … University; Concurrent radiation and combined bleomycin, ifosfamide... - Feb 16, 2005 The information in this article comes under the subject areas of Cervical Cancer, Oncology, Radiation Therapy, Bleomycin, Ifosfamide, Cisplatin, ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Ifosfamide injection.(NEW GENERICS)(Teva Health Systems)(Brief... - Sep 3, 2007 Teva Health Systems, Irvine, Calif., (949) 455-4700, is introducing three new generics. Ifosfamide injection, a generic alternative to Bristol-Myers ... $4.95 - Drug Topics - ECNext … Cancer; Concurrent radiation and combined bleomycin, ifosfamide, … - Feb 18, 2005 The information in this article comes under the subject areas of Cervical Cancer, Oncology, Radiation Therapy, Bleomycin, Ifosfamide, Cisplatin, ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Ifosfamide injection. - Sep 3, 2007 Ifosfamide injection, a generic alternative to Bristol-Myers Squibb's Ifex Injection, will be available as 50 mg/mL in 1-gm and 3-gm single-dose polymer ... $9.94 - Drug Topics - Alacra Store Ziopharm drug shows strong anticancer activity - Nov 3, 2006 Resistance to cyclophosphamide (CPA) and ifosfamide (IFOS) is a major obstacle to overcome in cancer treatment. CPA and IFOS are pro-drugs that cannot kill ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR. - Apr 16, 2007 ..."Ifosfamide has been tested as an oral drug but it is problematic at effective doses because of toxicity. Both an oral and IV form of ZIO-201 may offer ... Free with registration - Business Wire - AccessMyLibrary.com Pharmaceutical Research; Ziopharm presents preclinical kidney... - Mar 28, 2006 Cyclophosphamide and ifosfamide are widely used anticancer pro-drugs that ... ZIO-201 is the active metabolite of ifosfamide. Taub studied the effects of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Aggressive combined-modality therapy for squamous cell carcinoma of … - May 12, 2007 13 Combinations of taxanes and platinum, with and without ifosfamide, ... (2000) Ifosfamide, paclitaxel, and cisplatin for patients with advanced ... Nature.com FDA panel rejects mifamurtide for osteosarcoma in children - Jun 1, 2007 ..."There is no doubt that mifamurtide does interact with ifosfamide," committee ... The study was designed to test neoadjuvant ifosfamide in addition to ... HemOncToday Jonathan Lewis, MD, PhD, Appointed to Scientific Advisory - Dec 4, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It is expected to overcome the resistance of ifosfamide and cyclophosphamide in ... Bloomberg Sarcomi, allo studio una chemioterapia meno tossica - May 15, 2006 Tutti i pazienti sono stati sottoposti a una chemioterapia con mesna, doxorubicina, ifosfamide e dacarbazina (il cosiddetto schema MAID), poi a un ciclo di ... Corriere della Sera IGEV regimen and a fixed dose of lenograstim: an effective mobilizatio... - Oct 1, 2007 We explored the efficacy of the IGEV regimen (ifosfamide, gemcitabine, ... 23 The efficacy of the combination of ifosfamide and vinorelbine as salvage and ... Nature.com Soft Tissue Sarcoma; Licensed oncology drug for soft tissue sarcoma... - Jan 25, 2005 ZIO-201 is a metabolite of ifosfamide, a commonly used alkylating drug. The company believes that ZIO-201 has several advantages over ifosfamide in that it ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Myeloablative chemotherapy with autologous stem cell rescue for Ewing... - Aug 4, 2008 Because the addition of etoposide and ifosfamide was shown to improve outcome, ... The study of chemotherapy including etoposide and ifosfamide was also ... Nature.com Soft Tissue Sarcoma; Licensed oncology drug for soft tissue sarcoma... - Jan 24, 2005 ZIO-201 is a metabolite of ifosfamide, a commonly used alkylating drug. The company believes that ZIO-201 has several advantages over ifosfamide in that it ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones University of Gottingen, Germany; New research results reported by … - Nov 14, 2006 This CYP2B1 enzyme converts ifosfamide to its active cytotoxic compounds. ... Early ip treatment with ifosfamide and CYP2B1 cells resulted in a complete ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Soft Tissue Sarcoma; Licensed oncology drug for soft tissue sarcoma... - Jan 28, 2005 ZIO-201 is a metabolite of ifosfamide, a commonly used alkylating drug. The company believes that ZIO-201 has several advantages over ifosfamide in that it ... Pay-Per-View - Drug Week - Factiva, from Dow Jones High-dose chemotherapy with peripheral blood progenitor cell support... - Oct 8, 2007 Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with ... High dose combination chemotherapy with ifosfamide, cyclophosphamide, ... Nature.com Cancer Therapy; Use of agarose capsules chemotherapeutically targets ... - Jan 10, 2006 ..."Localized activation of the prodrug ifosfamide in or close to tumors by implanting encapsulated ifosfamide-activating cells is an efficacious strategy for ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Segregated graft-versus-tumor effect between CNS and non-CNS lesions ... - Mar 10, 2008 Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; ... Nature.com ZIOPHARM Receives Orphan Medicinal Product Designation for … - Oct 15, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It overcomes the resistance of ifosfamide and cyclophosphamide in certain cancers. ... Genetic Engineering News - Genetic Engineering News (press release) Ziopharm Initiates Trial of Sarcoma Drug - Feb 24, 2006 ZIO-201 is the active metabolite of ifosfamide, a frequently used, ... "We know that high-dose ifosfamide is an effective drug in treating patients with ... RedOrbit ZIOPHARM Oncology Reports Third Quarter Financial Results - Oct 31, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It is expected to overcome the resistance of ifosfamide and cyclophosphamide in ... RedOrbit Chemotherapy for metastatic NSCLC: current status and future direction - Feb 10, 2005 The mitomycin, ifosfamide and cisplatin (MIC) regimen is commonly used in ... Patients in the MIC arm received mitomycin 6 mg/m 2 , ifosfamide 3 g/m 2 and ... Nature.com ZIOPHARM Presents Darinaparsin Molecular Mechanism of Action and … - Oct 23, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It is expected to overcome the resistance of ifosfamide and cyclophosphamide in ... Genetic Engineering News - Genetic Engineering News (press release) ZIOPHARM To Host Analyst & Institutional Investor Meeting - Nov 3, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It is expected to overcome the resistance of ifosfamide and cyclophosphamide in ... International Business Times Prognostic significance of early lymphocyte recovery after post- … - Aug 6, 2007 ...cytosine arabinoside, platinum)); and ifosfamide-based regimens (MINE (mesna, ifosfamide, mitoxantrone, etoposide) or ICE (ifosfamide, carboplatin, ... Nature.com Oncology; Recent findings from Italy and the United States illuminate... - Nov 6, 2006 Study 1: The use of ifosfamide as childhood cancer therapy could be safer ... "The aim of this study was to compare long-term effects of ifosfamide versus ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones High-dose chemotherapy followed by stem cell rescue for high-risk... - Nov 10, 2008 3 described results of salvage therapy with paclitaxel, ifosfamide and cisplatin ... Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, ... Nature.com After beating cancer, the Tour de France seemed almost easy - Jun 28, 2005 Lance chose the ifosfamide, taking the short-term discomfort for the long-term gain." The brain surgery was performed on Oct. 24. ... SI.com A randomized study comparing filgrastim versus lenograstim versus … - Feb 22, 2006 Mobilization consisted of high-dose cyclophosphamide in 45 cases (44%), and cisplatin/ifosfamide/etoposide or vinblastine in 22 (21%), ... Nature.com Can the standard chemotherapeutic regimen be improved upon for small-... - Mar 1, 2006 To compare a regimen of ifosfamide, carboplatin, etoposide and ... ICE-V consisted of: day 1, ifosfamide (5 g/m 2 ) with mesna as a 24-h infusion, ... Nature.com Myeloablative therapy with autologous stem cell rescue for patients... - Feb 4, 2008 For patients with local disease, the addition of ifosfamide and etoposide to conventional therapy has led to PFS rates of 70% , whereas we observed lower ... Nature.com Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel... - Aug 13, 2007 Standard- and high-dose etoposide, ifosfamide, carboplatin, ... High dose combination chemotherapy with ifosfamide, cyclophosphamide cisplatin mitomycin C ... Nature.com On the Threshold of Relief for Older Men - Oct 28, 2005 In 2003, Threshold acquired glufosfamide, which is synthesized by combining glucose and an existing chemotherapy, ifosfamide. Ifosfamide carries substantial ... TheStreet.com - TheStreet.com (subscription) ZIOPHARM's ZIO-201 may have role in bone marrow transplant.(Brief … - Feb 27, 2006 Alkylators like cyclophosphamide and ifosfamide are widely used to prepare ... ZIO-201 is the active breakdown product of ifosfamide and therefore is not ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Autologous stem cell transplantation for high-risk Ewing's sarcoma... - Nov 7, 2005 Recently, the addition of ifosfamide and etoposide to induction chemotherapy ... 22 All patients with ES reported in our series received ifosfamide and ... Nature.com Second-line paclitaxel in non-small cell lung cancer initially... - Feb 12, 2007 Patients received three courses of induction GIP (gemcitabine, ifosfamide, cisplatin). Non-progressing patients were randomised between three further ... Nature.com Ziopharm initiates collaborative research agreement with Southern … - Jan 7, 2005 ZIO-201 is the stable active metabolite of ifosfamide, an alkylating drug. ... ZIO-201 has also been shown to be active in several ifosfamide- and ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com ZIOPHARM Oncology to Present at the Third Annual JMP Securities … - Sep 29, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It overcomes the resistance of ifosfamide and cyclophosphamide in certain cancers. ... RedOrbit ZIOPHARM Presents Positive Phase II Data for ZIO-201 in Soft Tissue... - Nov 5, 2007 ..."In addition, current treatments, particularly ifosfamide, carry with them a ... ZIO-201, the active moiety of ifosfamide (IFOS), is a bi-functional ... Genetic Engineering News - Genetic Engineering News (press release) Treatment for Germ Cell Tumors of the Ovary - Jan 19, 2008 These include paclitaxel (Taxol), ifosfamide, and cisplatin (TIP), a combination called VeIP (vinblastine, ifosfamide, and cisplatin), the combination of ... ACS News Center Shortened Time Between Chemotherapy Beneficial for Patients With … - Jun 1, 2008 Standard therapy in Europe already includes both ifosfamide and etoposide together, without alternating the 2 drugs, and without filgrastim support. ... DG News ZIO-201 Preclinical Data Demonstrate Effectiveness in Pediatric... - Nov 2, 2006 Cyclophosphamide and the related drug ifosfamide are widely used ... Resistance to cyclophosphamide (CPA) and ifosfamide (IFOS) is a major obstacle to ... Genetic Engineering News - Genetic Engineering News (press release) ZIOPHARM Commences Randomized Phase II Study of Palifosfamide in … - May 9, 2008 Palifosfamide delivers only the cancer fighting component of ifosfamide. It overcomes the resistance of ifosfamide and cyclophosphamide in certain cancers. ... Ad-Hoc-News - Ad-Hoc-News (Pressemitteilung) Ziopharm presents ZIO-201 preclinical data at AACR; Phase I clinical... - Apr 19, 2005 Data presented include L-IPM activity in cyclophosphamide- and ifosfamide-resistant cancers. L-IPM, unlike ifosfamide, is not metabolised to acrolein or ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Article: Smart bombs. - Australasian Business Intelligence | HighBeam... - May 30, 2007 Baseline measurements of personnel exposure to the chemotherapy drugs cyclophosphamide and ifosfamide were made in January 2002 ... demonstrated that after ... Pay-Per-View - Australasian Business Intelligence - HighBeam Research Collaborations; Collaborative research agreement initiated to develop... - Feb 8, 2005 ZIO-201 is the stable active metabolite of ifosfamide, an alkylating drug. ... ZIO-201 has also been shown to be active in several ifosfamide- and ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Cervical Cancer; Researchers' data advance cervical cancer research - Nov 14, 2005 Study 3: According to recent research from Japan, "Combination chemotherapy consisting of bleomycin, ifosfamide, and cisplatin (BIP) is recognized as one of ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Collaborations; Collaborative research agreement initiated to develop... - Feb 11, 2005 ZIO-201 is the stable active metabolite of ifosfamide, an alkylating drug. ... ZIO-201 has also been shown to be active in several ifosfamide- and ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Clinical Trials; Publication of abstract on isophosphoramide mustard... - Dec 27, 2005 Mesna, which is used as an "uroprotective" agent with ifosfamide, does not need to be given with ZIO-101. A phase I/II study with ZIO-201 in people with ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Okayama University, Japan; Research from Okayama University, Japan, … - Dec 5, 2006 Kaku and colleagues published their study in Acta Medica Okayama (Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones ZIOPHARM ZIO-201 Featured on ABC News. - Aug 8, 2006 ZIO-201, the Company's proprietary alkylating drug, is the active metabolite of ifosfamide and, unlike ifosfamide, does not produce the other metabolites ... $4.95 - Business Wire - ECNext Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC – a... - Nov 23, 2006 Gatzemeier U, Heckmayr M, Hossfeld DK, Kaukel E, Koschel G, Neuhauss R (1991a) A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine ... Nature.com High-dose chemotherapy with autologous stem cell transplantation as... - Apr 11, 2006 If a complete response (CR) or partial response (PR) was obtained, a chemotherapy regimen associating ifosfamide 1500 mg/m 2 on days 1–3 and cytarabine 1000 ... Nature.com Can dose-dense chemotherapy improve outcome in patients with better- … - Aug 12, 2005 The main dose-limiting toxicity of ifosfamide, carboplatin and etoposide (ICE) chemotherapy is hematologic, so the authors used filgrastim and autologous ... Nature.com Secondary dissemination in children with high-grade malignant gliomas... - Jul 31, 2006 ...consisting of two courses of induction chemotherapy (cisplatin and etoposide in the first and cisplatin, etoposide and ifosfamide in the second course). ... Nature.com Ewing's Family of Tumors - Dec 5, 2008 Multidrug chemotherapy for EFT always includes vincristine, doxorubicin, ifosfamide, and etoposide. Most protocols use cyclophosphamide as well. ... WebMD Are metastatic testicular tumors curable with high-dose chemotherapy ... - Aug 29, 2007 Patients who had already received ifosfamide-based salvage chemotherapy were given HDCT only. High-dose chemotherapy comprised two cycles of intravenous ... Nature.com Is high-dose chemotherapy effective in patients with relapsed or... - Oct 5, 2007 Patients who had already received ifosfamide-based salvage chemotherapy were given HDCT only. HDCT comprised two cycles of intravenous carboplatin (700 mg/m ... Nature.com Methotrexate, vinblastine, doxorubicin and cisplatin combination... - Aug 23, 2007 Krege S, Rembrink V, Börgermann C, Otto T, Rübben H (2001) Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic ... Nature.com A phase II study of vinflunine in bladder cancer patients progressing... - Apr 18, 2006 A variety of agents have been studied including ifosfamide, taxanes, oxaliplatin, ... Ifosfamide had been studied in the past, and its phase II results in ... Nature.com Vinflunine – an active chemotherapy for treatment of advanced non... - Jan 30, 2006 ...results of a phase III study of docetaxel vs vinorelbine/ifosfamide (Fossella et al, 2000) and another phase III study of docetaxel vs supportive care. ... Nature.com La chimiothérapie adjuvante des sarcomes - Oct 1, 2005 Une étude de l'EORTC randomise 340 patients pour recevoir ou non l'association doxorubicine-ifosfamide. La place de la chimiothérapie adjuvante par rapport ... john-libbey-eurotext.fr Prospective single-arm study of pegfilgrastim activity and safety in ... - Jul 21, 2008 The ICE schema (ifosfamide 2 g/m 2 per day, iv for 3 days+carboplatin 400 mg/m 2 per day, iv for 2 days+etoposide 150 mg/m 2 per day, iv for 3 days) was ... Nature.com A comparison of patients with relapsed and chemo-refractory gestationa... - Nov 23, 2006 Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage ... High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the ... Nature.com Press Release: Threshold Pharmaceuticals Initiates Phase 2 Clinical... - Apr 9, 2007 Doxorubicin and ifosfamide are the most commonly used chemotherapeutic ... Article: Doxorubicin with or without ifosfamide in treating patients with ... ... Pay-Per-View - PR Newswire - HighBeam Research Intensive induction chemotherapy with C-BOP/BEP for intermediate- and... - Oct 25, 2005 ...ifosfamide, cisplatin, bleomycin) with four cycles BEP plus two cycles of EP (Kaye ... or ifosfamide in the treatment of disseminated germ cell tumors. ... Nature.com Randomised phase II trial of irinotecan plus cisplatin vs irinotecan,... - Oct 15, 2007 The addition of ifosfamide or cyclophosphamide and epirubicin to the cisplatin and etoposide combination produced a slight survival benefit, ... Nature.com Clinicians Introduce Guidelines for Diagnosis and Treatment of... - Mar 21, 2007 ICE (ifosfamide, carbolated, etoposide), MiniBeam (carmustine, etoposide, cytarabine, and melphalan), and MINE (mesna, ifosfamide, mitoxantrone, ... DG News Treatment of diffuse large B-cell lymphoma of the liver with yttrium... - Sep 25, 2007 After two cycles of rituximab, ifosfamide, carboplatin, and etoposide (R-ICE), a restaging PET-CT scan revealed a very modest response, with decreased 18 ... Nature.com ZIOPHARM Oncology Presents Positive Data From Studies Of … - Nov 19, 2008 STS revealed 3-month progression free rates of 45% overall and 55% in ifosfamide-naïve patients. The 6-month progression free rate was 23% at 6 months. ... Medical News Today - Medical News Today (press release) OTCPicks.com Stocks to Watch for Wednesday, February 6th IDMI, … - Feb 6, 2008 Patients were randomly assigned to receive or not to receive ifosfamide and/or MTP in a 2x2 factorial design. In the published analysis, the chemotherapy ... Free with registration - M2 Presswire - AccessMyLibrary.com ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH. - Mar 23, 2007 ZIO-201 is a proprietary form of the therapeutic active metabolite of ifosfamide (IFOS), a drug that is widely used in the treatment of lymphoma. ... Free with registration - Business Wire - AccessMyLibrary.com ZIOPHARM Commences Treatment of First Patients in Two Separate … - Feb 4, 2008 ZIOPHARM is developing several proprietary stabilized forms of palifosfamide (isofosforamide mustard or IPM), the cancer targeting component of ifosfamide, ... Lifescience-online IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study … - Feb 4, 2008 Patients were randomly assigned to receive or not to receive ifosfamide and/or MTP in a 2x2 factorial design. In the published analysis, the chemotherapy ... Free with registration - PR Newswire - AccessMyLibrary.com EWING SARCOMA OF THE RIB: RESULTS OF AN INTERGROUP … - Jan 1, 2005 Ifosfamide and etoposide improved outcome in the overall group (5-year event-free survival, 68% vs 54%; P = .002), and a similar trend occurred in chest ... The Journal of Thoracic and Cardiovascul... Rhabdomyosarcoma of the middle ear and mastoid: a case report and … - Dec 1, 2005 ...(7) The chemotherapeutic element of the IRS IV protocol is significantly different from its predecessors in that the newer agents etoposide, ifosfamide, ... Free with registration - Ear, Nose and Throat Journal - AccessMyLibrary.com New Approaches to Neuroblastoma - Jun 1, 2007 These include cisplatin/ifosfamide, carboplatinum/ifosfamide, and vincristine cytotoxins," he explained. "Everybody uses variants of these protocols, ... Psychiatric Times Pancreatic cancer: still grim reaper: it's a deadly disease, but new ... - Feb 21, 2005 ...combines the active part of an approved alkylator, ifosfamide, ... Inside cells, the linkage between glucose and ifosfamide is cleaved to release the active ... Free with registration - Drug Topics - AccessMyLibrary.com Bladder cancer.(Clinical Trial watch) - Apr 1, 2006 Phase II Study of Neeadjuvant Chemotherapy Comprising Ifosfamide, Doxorubicin, and Gemcitabine Followed By Cisplatin, Gemcitabine, and Ifosfamide in ... Free with registration - Urology Times - AccessMyLibrary.com Bladder cancer.(Clinical Trial watch) - Jan 1, 2006 Phase II Study of Neoadjuvant Chemotherapy Comprising Ifosfamide, Doxorubicin, and Gemcitabine Followed By Cispiatin, Gemcitabine, and Ifosfamide in ... Free with registration - Urology Times - AccessMyLibrary.com Therapy Insight: malignant primary cardiac tumors - Jun 6, 2005 The most common regimen, used for many sarcomas, is combined doxorubicin and ifosfamide. The best results are obtained with dose-intensive chemotherapy, ... Nature.com The risk of thrombo-embolic events is increased in patients with germ... - Oct 4, 2005 However, all of them received cisplatin-based chemotherapy; 31% of them received the rapidly recycled cisplatin, doxorubicin, and ifosfamide (API-AI) ... Nature.com Cancer Therapy; Research in cancer therapy provides new insights - Mar 14, 2006 Keywords: Milan, Italy, Chemotherapy, Doxorubicin, Oncology, Pediatric, Prognosis, Prognostics, Sarcoma, Adult-Type, Retrospective Analysis, Ifosfamide, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones NOVACAPS Austrianova partnering opportunity, Worldwide.(Austrianova … - Dec 11, 2006 NOVACAPS comprises genetically modified, cellulose phosphate encapsulated cells that overexpress cytochrome P450, which converts ifosfamide into tumor toxic ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Brand Names/Synonyms: Ifosfamide is also known by the following brand names and/or synonymsA 4942; Asta Z 4942; Cyfos; Holoxan 1000; I-Phosphamide; IFEX; Ifex; Ifex/Mesnex Kit; Ifosfamid; Ifosfamide; Ifosfamide Sterile; Ifosfamide/Mesna Kit; Ifsofamide; Iphosphamid; Iphosphamide; Isoendoxan; Isofosfamide; Isophosphamide; MJF 9325; Mitoxana; Naxamide; Z 4942 Drug Category: Ifosfamide is categorized under the following by the FDA: Antineoplastic Agents; Immunosuppressive Agents; ATC:L01AA06 Dosage Forms: Powder for solution Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N,3-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |